estrogens progestins pharm Flashcards

1
Q

estrogen/progesterone metabolism

A

•degraded rapidly on 1st-pass through liver; analogs that have reduced hepatic degradation have been developed for oral use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Define the principal estrogens/progestins in humans
A

Estradiol (E2):most abundant and potent estrogen in menstruating wome. Estrone (E1): 2nd most potent estrogen, the predominant estrogen during menospause. Estriol (E3): weak estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Define the estrogen-like compounds in our environment.
A

A. phytoestrogens - occur in plants, fruits, veggies. have estrogenic and antiestrogenic activities: 1) isoflavones are most potent (genistein and diazein in soybeans, chickpeas, lentils) 2) coumestans: split peas, lima beans, 3) lignans (enterolactone and enterodiol found in flaxseed, lentils, grains, fruits, veggies, ). B. bisphenol A- a synthetic compound used in plasticizers; has weak affinity but its bioaccumulation in the environment has raised concerns about potential toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sites of estrogen synthesis in pre vs post menopausal women (and men)

A

Premenopausal: ovarian theca and granulosa cells. Men and postmenopausal: adipose tissues (estrone is synthesized from androstenediol secreted by the adrenal cortex) and conversion of test to estradiol via aromatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

compare levels of estrogen in pre vs post menopausal and men

A

premenopausal: early follicular (40-200 pg/ml); preovulatory (250-500 pg/ml); midluteal (100-150 pg/ml). Post menopausal/ men: <20pg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

biosynthetic pathway of estrogen production

A

cholesterol > pregnenolone > progesterone > androstenedione > estrone (aromatase)> estradiol. OR androstenedione > testosterone > estradiol (aromatase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

two cell theory of estrogen synthesis

A

the theca cells secrete androgens that diffuse to the granulosa cells to be aromatized to estrogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tissue locations of aromatase

A

granulosa cells, adipose tissue, muscle and brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Estrogen feedback regulation

A

estrogen feeds back primarily at the level of the pituitary to inhibit LH/FSH secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Describe the mechanism of action of estrogens.
A

Estrogen (E) binds to ER and facilitates dimerization and interaction with estrogen response element (ERE) sequences in DNA. The ER-DNA complex recruits co-activators SWI/SNF and SRC-1. SRC-1 has histone acetyltransferase activity that alters chromatin structure. This remodeling facilitates the exchange of the recruited proteins such that other co-activators (p300 and TRAP) bind to the gene promoter and recruit proteins that comprise the general transcription apparatus (GTA) resulting in synthesis of mRNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe MOA of estrogen receptor antagonists

A

ie. Tamoxifen. Binds ER facilitating dimerization, but recruits co-repressors NcOR. NcOR recruits histone deacetylase I which stabilizes nucleosome and prevents interaction with the general transcription apparatus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The recruitment of factors by the estrogen receptor depends on

A

The ligand and tissue that the receptor is in

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of estrogen receptors and which hormones bind to them

A

ER alpha and beta: 17b-estradiol bind equally to Era and Erb. Estrone has higher affinity for Era. Phytoestrogens genistein and coumestrol have higher affinity for Erb.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

tissue distribution of estrogen receptors

A

ER b: granulosa cells, kidney, intestinal mucosa, lung, bone marrow, brain, prostate. ER a: endometrium, breast cancer cells and ovarian stroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Therapeutic uses of estrogens

A

Hypogonadism (plus progestin if uterus intact), menopause, menopause (plus calcium, Vit D and bisphosphanates), contraception (plus progestin to inhibit production of LH/FSH and GnRH), PCOS (plus spironolactone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Estrogen use in menopause

A

alleviate vasomotor instability, emotional lability, sleep disturbances, atrophy of estrogen-dependent tissues, and osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Modifications to estradiol to increase lipid solubility and decrease degradation by liver

A

Estradiol is esterified at 17-beta position (R3) to increase lipid solubility. Adding an ethinyl group at position 17 (R2) decreases degradation by the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

List the esterified estrogens

A

estradiol valerate and estradiol cypionate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

List the estrogens with ethinyl group added

A

ethinyl estradiol, mestranol, and quinestrol

20
Q

compare the routes of estrogen meds and associated risks

A

Oral estrogen increases hepatic production of thyroxine-binding globulin, corticosteroid-binding globulin, sex hormone-binding globulin, triglycerides, high-density lipoprotein (HDL) cholesterol, and clotting factors, whereas their production is only minimally increased by transdermal estrogen administration. Transdermal has lower risk of venous thromobosis and stroke

21
Q

List the preparations of 17-B-estradiol, 17-B-estradiol esters, synthetic conjugated estrogens (estrone sulfate), conjugated equine estrogens (Premarin) and ethinyl estradiol

A

17-B-estradiol: oral (micronized), transdermal, vaginal cream, vaginal ring. 17-B-estradiol esters: oral, IM. Synthetic conjugated estrogens (estrone sulfate): oral. Conjugated equine estrogens (Premarin): oral, HRT. ethinyl estradiol: birth control pill

22
Q

Risks and side effects of estrogens

A

Increased risk of cancer (endometrial, lung, vaginal/cervical cancer in offspring), stroke, heart attack, blood clots, gall bladder dz, migraine, nausea, and changes in lipid metabolism

23
Q

Which cancer risk is increased with progestin

A

breast cancer

24
Q

SERMs MOA

A

display agonistic or antagonistic activities depending on tissue and endpoint.

25
Q

List the effects of SERM agonists at the breast, endometrium, bone, CV system, CNS and liver

A

Breast: promotes cancer. Endometrium: promotes cancer. Bone: maintain bone density, anti-resorptive. Cardiovascular system: arterial dilation. CNS: cognitive and neuroprotective. Liver: Stimulates uptake of serum lipoproteins, increases synthesis of coag factors.

26
Q

“ideal SERM” for hormone replacement

A

antagonist in endometrium and breast. agonist in bone, cardiovascular system, CNS

27
Q

Tamoxifen MOA and uses

A

SERM used in the treatment of breast cancer, act as antagonist at breast but agonist in endometrium ( because of risk of endometrial cancer used for less than 5 years)

28
Q

Raloxifene MOA and uses

A

SERM used for osteoporosis, acts as a partial agonist in bone and does not stimulate endometrial proliferation

29
Q

Toremiphene MOA and uses

A

SERM used in the treatment of breast cancer, act as antagonist at breast but agonist in endometrium ( because of risk of endometrial cancer used for less than 5 years)

30
Q

Clomiphene MOA and uses

A

SERM used for treatment of infertility, induces ovulation by antagonizing inhibitory actions of estrogen at level of pituitary, partial agonist at endometrium and causes hot flashes

31
Q

Femarelle uses

A

SERM used for Menopause symptoms and maintaining bone health

32
Q

List Antiestrogens and uses

A

Fulvestrant- treatment of breast cancer

33
Q

List the aromatase inhibitors

A

anastrozole (arimidex)and letrozole (femara) are non-steroidal, competitive. exemestane (aromasin) and formestane (lentarin) are steroidal, non-competitive

34
Q

Aromatase inhibitors MOA and uses

A

Block production of estrogens from androstenediol or testosterone. used for the treatment of breast cancer, primarily in postmenopausal women. Superior to Tamoxifen. No stimulation of endometrium.

35
Q

Aromatase inhibitors side effects

A

joint disorders, osteoporosis, hypercholesterolemia

36
Q

List the principle progestins

A

Progesterone and 17alpha-hydroxyprogesterone

37
Q

Sites of progesterone biosynthesis in men and women

A

Premenopausal women: synthesized mainly by corpus luteum. also in adrenal cortex and placenta. Men and postmenopausal women: Testis and/or adrenal cortex

38
Q

List the normal concentrations of progesterone in men and women

A

Premenopausal women: follicular phase (95mg/dl); luteal phase (1000ng/dl). Men and postmenopausal women: 15-90ng/dl

39
Q

Mechanism of action of progestins

A

•cytosolic receptor that translocates to nucleus and regulates gene transcription via progesterone response elements.

40
Q

Progestin receptor forms

A

A and B. PR receptor is induced by estrogen as well

41
Q

Therapeutic uses of progestins

A
  1. contraception: combo pill (estrogen plus small amount of progestin), progestin only pill (less effective), postcoital contraceptives (high dose intereferes with implantation). 2. HRT: used with estrogens. 3. Ovarian suppression: dysmenorrhea, endometriosis, uterine bleeding
42
Q

How does progestin work as contraception

A

Decreases frequency of hypothalamic pulse generator

43
Q

Progesterone preparations

A

micronized oral form (Prometrium), injectable oil-based solution, vaginal cream, IUD

44
Q

Progesterone esters preparations

A

medroxyprogesterone acetate is given orally (Provera) or IM administration (Depo-Provera)

45
Q

19-nortestosterone derivatives preparations

A

norethindrone, norgestrel are given orally with estrogen for contraception. norgestrel is also given as subdermal implant (Norplant). etronorgestrol released with ethinyl estradiol (Nuva ring). norelgestromin and ethinyl estradiol released transdermally (Evra patch); superior compliance to OCP.

46
Q

Preparation of progesterone that decreases hepatic degradation

A

Substitution at the 6-position decreases hepatic degradation making MPA orally active. Ethinyl substitution of 19-nortestosterone decreases hepatic degradation making more orally available

47
Q

List anti-progestins and their uses

A

Mefipristone (RU 486)- used to terminate pregnancy by acting as competitive antagonist at level of uterus. Can also act as postcoital contraceptive by preventing ovulation via effects on hypothalamus. Given with prostaglandins